.png){kind=icon}
返回
The mRNA decapping complex is buffered by nuclear localization
.png){kind=icon}
OA
AI
DOI：10.1242/jcs.259156.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
mRNA decay is a key step in regulating the cellular proteome. Processing bodies (P-bodies) are thought to be sites of mRNA decay and/or storage. P-body units assemble into P-body granules under stress conditions. How this assembly is regulated, however, remains poorly understood. Here, we show, in the yeast Saccharomyces cerevisiae, that the translational repressor Scd6 and the decapping stimulator Edc3 act partially redundantly in P-body assembly by sequestering the Dcp1-Dcp2 (denoted Dcp1/2) decapping complex in the cytoplasm and preventing it from becoming imported into the nucleus by the karyopherin beta protein Kap95. One of two nuclear localization signals in Dcp2 overlaps with the RNA-binding site, suggesting an additional mechanism to regulate Dcp1/2 localization. Nuclear Dcp1/2 does not drive mRNA decay and might be stored there as a readily releasable pool, indicating a dynamic equilibrium between cytoplasmic and nuclear Dcp1/2. Cytoplasmic Dcp1/2 is linked to Dhh1 via Edc3. Functional P-bodies are present at the endoplasmic reticulum where Dcp2 potentially acts to increase the local concentration of Dhh1 through interaction with Edc3 to drive phase separation and hence P-body formation.
Keyword:
mRNA
Nucleo-cytoplasmic transport
Processing bodies
Membraneless granules
Phase separation
Endoplasmic reticulum
期刊
IF:
3.6
论文数:
1.1W
被引数:
3.7W
机构
引用论文
分享收藏Closures of coal‐fired power stations in Australia: local unemployment effects澳大利亚燃煤发电站关闭: 当地失业影响
OAAI
OAAI分享收藏Scd6 Targets eIF4G to Repress Translation: RGG Motif Proteins as a Class of eIF4G-Binding Proteins.png)
MOLECULAR CELLOAAI
MOLECULAR CELLIF16.6
OAAI分享收藏Conserved mRNA-granule component Scd6 targets Dhh1 to repress translation initiation and activates Dcp2-mediated mRNA decay in vivoPLOS GENETICSOAAI
PLOS GENETICSIF3.7
OAAI分享收藏A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's diseaseGut
GutIF0
PREAI
分享收藏
查看更多内容